ResearcherUniversity of Illinois ChicagoNo recent work listed

Manu Gnanamony

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-1893-6603; OpenAlex author ID A5090550125.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

Chemoresistance in pancreatic cancer: Emerging concepts. First author DOI 10.3892/ol.2017.5777 ↗
The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review). Co-author DOI 10.3892/ijo.2016.3417 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Christopher S. Gondi · 2 shared papers, 2016–2017
- Paper Chemoresistance in pancreatic cancer: Emerging concepts. DOI 10.3892/ol.2017.5777 ↗
- Paper The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review). DOI 10.3892/ijo.2016.3417 ↗
Monica K. Rossi · 1 shared paper, 2016
- Paper The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review). DOI 10.3892/ijo.2016.3417 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.